JAGX
JAGX
NASDAQ · Pharmaceuticals

Jaguar Health Inc

$0.40
0.00 (-0.69%)
As of Nov 7, 2:59 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +11,747.6% upside
Low Target $35.39
Average Target $47.90
High Target $54.68
Current Price $0.40
Current
$0.40
Target
$47.90
$35.39 $47.90 avg $54.68
Scenario Analysis
Bear Case
$35.39
8,653.4%
Low target
Base Case
$47.90
+11,747.6%
Avg target
Bull Case
$54.68
+13,424.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
Target vs 52W High
$47.90
-95.7% vs high
Next Earnings Report
Nov 12, 2026
4d
until earnings
EPS Est: $-1.19
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%